Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
Latest Jobs
Exclusive vacancies may not be shown here, please contact Matthew on +44 1494 818 054 or for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Matthew Moxon
Account Manager
+44 1494 818 054

Working as a hospital specialist contractor for Zenopa has been a very positive experience. My contract manager was great. I genuinely felt she was on my side wanting me to do well.
Sadie, 2011

Systagenix wins Gatwick Diamond Business Award for WoundChek

5 April 2012 00:00 in Medical Company Product News

Systagenix has been awarded with a prestigious Gatwick Diamond Business Award for its pioneering WoundChek Protease Status device.

The company was presented with the award for innovation and technology after demonstrating the way in which its first-of-a-kind product is enhancing business performance.

Launched earlier this year, WoundChek is a unique point-of-care diagnostic test for wounds that allows elevated protease activity to be rapidly identified, which in turn makes it easier to diagnose chronic problems.

Having been granted CE Mark accreditation, the device achieved its first sale in February 2012 after being purchased by Brentwood Community Hospital.

Victory at the Gatwick Diamond Business Awards saw Systagenix successfully compete with more than 450 international firms, underlining the revolutionary nature of the product launch.

Ernest Waaser, chief executive officer of Systagenix, said: "Bringing Woundchek Protease Status to the market is a huge achievement for Systagenix and a long-awaited innovation milestone in the woundcare field."ADNFCR-8000103-ID-801334913-ADNFCR

Other news stories from 05/04/2012

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency

© Copyright 2015 Zenopa Ltd